Redefining chronic disease care with
GLP-1 therapies
September 16-17, 2025
Once confined to diabetes management, glucagon-like peptide-1 (GLP-1) receptor agonists are now driving innovation across a broader spectrum of chronic diseases, such as obesity, cardiovascular conditions and neurodegenerative disorders.
This series of expert-led sessions will explore the emergence of next-generation GLP-1 therapies, highlight clinical strategies enabling expanded indications and unpack the scientific advancements pushing peptide therapeutics to new heights
As these potent incretin mimetics continue to disrupt markets and fuel unprecedented demand, attendees will gain valuable insights into where the science is headed and how the industry is responding.
You will shortly be able to register for fireside chats and keynote presentations from the world’s leading innovators, vendors and evangelists.
September 16-17, 2025
Audience
MDs, Heads, EVPs, SVPs, VPs, Directors, Managers, Practitioners, and Consultants within:
Pharma / Life Sciences / Medicine
Digital CMC / Digital Technologies
Data & Analytics / Strategy
Business Operations
Healthcare Operations / Healthcare Innovation
Medical Value
Pharmacogenomics
Cell & Gene Therapy
Healthcare Pricing & Strategy
Previous Speaking and Attending Companies
AbbVie Inc., Academy of Managed Care Pharmacy, Aetna Inc, Alcon Laboratories, Inc., Aliados Health, Alkermes, Inc., Alnylam Pharmaceuticals, Inc., Astellas Pharma Inc., AstraZeneca Plc, Atrium Health, Avalere Health LLC, Ballad Health, Bangkok Hospital, Bausch Health, Baxter International, Bayer AG, Benefis Healthcare, Biossil, BJC HealthCare, Blue Cross and Blue Shield of North Carolina, Bluestream Health, Boston Medical Center, Bristol-Myers Squibb Company, CancerCare Manitoba Foundation Inc., Care2Care International, Catalia Health, Cepheid Inc., Centers for Disease Control and Prevention
Children’s Medical Center, Clinuvel Pharmaceuticals Ltd, Colorado Pharmacy Society, CommonSpirit Health, Duke University, EagleForce Health LLC, Essentia Health, Free Market Health, Genentech, Inc., Gold Coast Health Plan, Grifols Inc., Guidewell Hawler Medical University, Healthcentric Advisors, Highmark Health, Hoffmann-La Roche Inc., Hudson Valley Heart Center, Indiana University Health, Intermountain Health Care, InC., J.P. Morgan & Co., Kaiser Permanente, Lupin Pharmaceuticals, M&T Bank, Marathon Health, Mayo Foundation for Medical Education & Research
Medical Research Council, Medicare Payment Advisory Commission, Medstar, Merge Healthcare, Morgan Stanley & Co., Mount Sinai Hospital, MountainStar Healthcare Network, MVP Health Care Inc., National Institutes of Health, National Nurses In Business Association, Inc., naviHealth, New York University Langone Medical Center, Northwell Health, Ohio Pharmacists Association, Oklahoma Health Care Authority, Oklahoma State University, Pacira Pharmaceuticals, Palomar Health, Penn Medicine, Penn State Health, PerkinElmer, Pharmaceutical Care Management Association
PrimeWest Health, Renown Health Foundation Rhode Island Department of Health, Sabio Health, Sanford Health, Story Health, St Petersburg State University, Strathmore University, Superior Biologics, Tabia Health, Taiho Oncology, Inc., Takeda Pharmaceutical Company, Texas Tech University, The Advisory Board Company, The Merck Group, The Wellness Centre, UnitedHealthcare, University of Michigan, University of New Hampshire, University of North Carolina at Chapel Hill, University of Pittsburgh Medical Center, Walgreens, West Pharmaceutical Services Inc., WEX Health, and more!